Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | TYMP | P19971 | 1/20 | 0.44 |
| ▸ | TK1 | P04183 | 4/20 | 0.43 |
| ▸ | TK2 | O00142 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26034606 | 0.87 | TK2 (0.53) | TYMPTK1TK2 | |
| SCHEMBL26035285 | 0.87 | TK2 (0.53) | TYMPTK1TK2 | |
| SCHEMBL24322118 | 0.86 | TYMP (0.54) | LMNATYMPTK1TK2 | |
| SCHEMBL21695505 | 0.80 | LMNA (0.74) | LMNATYMPTK1 | |
| SCHEMBL26035287 | 0.77 | TSHR (0.44) | TYMPTK1TK2 | |
| SCHEMBL2153546 | 0.76 | LMNA (0.56) | LMNATYMPTK1 | |
| SCHEMBL24205081 | 0.75 | TSHR (0.45) | TYMPTK1TK2 | |
| SCHEMBL24205266 | 0.73 | CYP2C9 (0.47) | LMNATK1TK2 | |
| SCHEMBL26035300 | 0.72 | LMNA (0.50) | LMNATK1TK2 | |
| SCHEMBL16092906 | 0.72 | TYMP (0.52) | TYMPTK1TK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10851179-B2 | Polysaccharide derivatives and cross-metathesis processes for preparing them | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2020-12-01 | — | — | US | disclosed |
| US-10738134-B2 | Cross-metathesized polysaccharide derivatives and processes for preparing them | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2020-08-11 | — | — | US | disclosed |
| US-20160215068-A1 | CROSS-METATHESIZED POLYSACCHARIDE DERIVATIVES AND PROCESSES FOR PREPARING THEM | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| WO-2015048408-A1 | CROSS-METATHESIZED POLYSACCHARIDE DERIVATIVES AND PROCESSES FOR PREPARING THEM | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2015-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10738134-B2 | Cross-metathesized polysaccharide derivatives and processes for preparing them | GYS1, SI, OSBP | LMNA 4028/4885TYMP 3604/4885TK1 3998/4885 |
| US-20160215068-A1 | CROSS-METATHESIZED POLYSACCHARIDE DERIVATIVES AND PROCESSES FOR PREPARING THEM | SI, OSBP, GYS1 | LMNA 4565/4885TYMP 3184/4885TK1 3655/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.